文献速递胸部腹部外周血管CT

双能CT诊断COVID-19相关系统性微血管病患者的肺与肾灌注缺损

Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.
PubMed 文献 · Eur Radiol · 2020-08-29

纳入31例疑似肺血栓栓塞的COVID-19患者行肺动脉双能CT血管成像,8例(25.8%)见肺灌注缺损且不重叠于磨玻璃影或实变区,13例(50%)肾碘图呈不均匀强化提示灌注异常;肺灌注缺损与病情更重、ICU入住率更高及D-二聚体≥0.485 μg/L相关(预测特异度100%、敏感度87%,AUROC 0.957)。

要点

  • 肺DECT可见不重叠于磨玻璃影或实变区的灌注缺损,提示微血管阻塞。
  • D-二聚体≥0.485 μg/L预测肺灌注缺损:特异度100%、敏感度87%、AUROC 0.957。
  • 肾碘图不均匀强化提示亚临床系统性微血管阻塞,可伴血钠降低。

核心结论

  • 较大比例轻至中度COVID-19患者肺和肾存在灌注缺损,可能提示系统性微血管病伴微血栓形成。
  • 这些发现有助于理解低氧血症的生理机制,并可能对COVID-19患者管理(如早期血栓预防或抗凝指征、优化氧疗策略)有启示。

研究设计与样本

  • 研究类型为对31例COVID-19患者的影像与临床资料分析,患者均行肺动脉双能CT血管成像且疑似肺血栓栓塞。
  • 回顾肺与肾双能CT图像,比较有无肺灌注缺损患者的临床特征与实验室检查。

关键影像表现/征象

  • 8例(25.8%)DECT示肺灌注缺损,且缺损区不与磨玻璃影或实变区重叠。
  • 肺灌注缺损患者中2例经CT血管成像确诊肺血栓栓塞。
  • 肾碘图显示13例(50%)呈不均匀强化,符合灌注异常。

诊断标准与关键数值

  • D-二聚体≥0.485 μg/L预测肺灌注缺损:特异度100%、敏感度87%(AUROC 0.957)。

临床应用与阅片要点

  • 阅片时应在肺DECT上寻找与磨玻璃影或实变不重叠的灌注缺损,作为微血管阻塞的征象。
  • 肺灌注缺损组住院时间更长(p=0.14)、ICU入住率更高(p=0.02)、病情更重(p=0.01)。
  • 肺灌注缺损组血清铁蛋白、天冬氨酸氨基转移酶、纤维蛋白原、D-二聚体、C反应蛋白及肌钙蛋白水平显著更高,白蛋白水平更低(p<0.05)。
  • 肾灌注异常组血钠水平更低(p=0.03)。
  • 作者认为这些发现可能对早期血栓预防或抗凝指征、优化氧疗策略有启示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: There is increasing evidence that thrombotic events occur in patients with coronavirus disease (COVID-19). We evaluated lung and kidney perfusion abnormalities in patients with COVID-19 by dual-energy computed tomography (DECT) and investigated the role of perfusion abnormalities on disease severity as a sign of microvascular obstruction.

METHODS: Thirty-one patients with COVID-19 who underwent pulmonary DECT angiography and were suspected of having pulmonary thromboembolism were included. Pulmonary and kidney images were reviewed. Patient characteristics and laboratory findings were compared between those with and without lung perfusion deficits (PDs).

RESULTS: DECT images showed PDs in eight patients (25.8%), which were not overlapping with areas of ground-glass opacity or consolidation. Among these patients, two had pulmonary thromboembolism confirmed by CT angiography. Patients with PDs had a longer hospital stay (p = 0.14), higher intensive care unit admission rates (p = 0.02), and more severe disease (p = 0.01). In the PD group, serum ferritin, aspartate aminotransferase, fibrinogen, D-dimer, C-reactive protein, and troponin levels were significantly higher, whereas albumin level was lower (p < 0.05). D-dimer levels ≥ 0.485 μg/L predicted PD with 100% specificity and 87% sensitivity. Renal iodine maps showed heterogeneous enhancement consistent with perfusion abnormalities in 13 patients (50%) with lower sodium levels (p = 0.03).

CONCLUSIONS: We found that a large proportion of patients with mild-to-moderate COVID-19 had PDs in their lungs and kidneys, which may be suggestive of the presence of systemic microangiopathy with micro-thrombosis. These findings help in understanding the physiology of hypoxemia and may have implications in the management of patients with COVID-19, such as early indications of thromboprophylaxis or anticoagulants and optimizing oxygenation strategies.

KEY POINTS: • Pulmonary perfusion abnormalities in COVID-19 patients, associated with disease severity, can be detected by pulmonary DECT. • A cutoff value of 0.485 μg/L for D-dimer plasma levels predicted lung perfusion deficits with 100% specificity and 87% sensitivity (AUROC, 0.957). • Perfusion abnormalities in the kidney are suggestive of a subclinical systemic microvascular obstruction in these patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Idilman IS, Telli Dizman G, Ardali Duzgun S, et al. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy. Eur Radiol. 2020. PMID: 32860146. doi:10.1007/s00330-020-07155-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。